A noninclusion virus of blow-fly larvae.

J Invertebr Pathol

Published: March 1969

Download full-text PDF

Source
http://dx.doi.org/10.1016/0022-2011(69)90226-2DOI Listing

Publication Analysis

Top Keywords

noninclusion virus
4
virus blow-fly
4
blow-fly larvae
4
noninclusion
1
blow-fly
1
larvae
1

Similar Publications

Guardian of society: Civil society in Nigeria's response to COVID-19 pandemic.

J Emerg Manag

August 2024

University of Religions and Denominations, Qom, Iran; Lecturer, Department of Political Science and International Relations, Anchor University, Lagos, Nigeria. ORCID: https://orcid.org/0000-0003-1135-6347.

The rapid breakout and dissemination of the coronavirus disease 2019 (COVID-19) infection from the city of Wuhan, China, to the rest of the countries of the world in December 2019 triggered a situation that led the World Health Organization to report it as a global public health emergency. The pandemic resulted in abrupt and significant loss of lives, disruption of economies, loss of livelihoods, and severe hardship across the nations of the world. Nigeria encountered the COVID-19 reality following the discovery of the first case of the infection in the country on February 27, 2020, prompting the government to swing into action to contain its spread.

View Article and Find Full Text PDF

Aim: To evaluate the efficacy and safety of riamilovir in the treatment of COVID-19 in adults.

Materials And Methods: The study included 180 patients with a laboratory-confirmed diagnosis of COVID-19 which fully meet the criteria for inclusion, non-inclusion and exclusion, signed a voluntary informed consent to participate in a clinical trial.

Results: The efficacy, good tolerability and safety of the drug riamilovir in the treatment of COVID-19 have been established.

View Article and Find Full Text PDF
Article Synopsis
  • In France, a study was conducted to estimate the prevalence of HIV, hepatitis C (HCV), and hepatitis B (HBV) among detainees at a detention center using Rapid Diagnostic Tests (RDT).
  • Out of 726 eligible detainees, 345 participated, showing a prevalence of 0% for HIV, approximately 4.64% for HCV, and 2.32% for HBV.
  • The results emphasized the importance of screening detainees for these infections and the effectiveness of RDTs in identifying cases.
View Article and Find Full Text PDF

Aim: Evaluation of the efficacy and safety of riamilovir as a drug for the prevention of coronavirus infection (COVID-19) in adults who have constant contact with COVID-19 patients as a result of living together.

Materials And Methods: The study included 750 adult participants living with patients with confirmed polymerase chain reaction method COVID-19, who had a negative polymerase chain reaction result for the SARS-CoV-2 virus at the initial level, met the criteria for inclusion, non-inclusion and exclusion, and signed a voluntary informed consent to participate in a clinical trial.

Results: The efficacy, good tolerability and safety of the drug riamilovir for the prevention of COVID-19 infection among people who have come into contact with COVID-19 patients in a family focus of infection have been established.

View Article and Find Full Text PDF

Background: Given the characteristics of military missions, intense interpersonal contact, and wide variation in casual relationships, the military has long been recognized as a high-risk population for sexually transmitted infections (STIs).

Objective: To assess the prevalence of STIs and socioepidemiological profile of women in the military garrison of Campinas.

Design And Setting: This prospective, cross-sectional epidemiological study, assisted by the Health Fund in the military garrison of Campinas, assessed the prevalence of human immunodeficiency virus (HIV), hepatitis B and C, syphilis, human papillomavirus (HPV), chlamydia, and gonococcus in military women or companions of soldiers with active or previously active sexual life.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!